FR2081436A1 - - Google Patents

Info

Publication number
FR2081436A1
FR2081436A1 FR7101185A FR7101185A FR2081436A1 FR 2081436 A1 FR2081436 A1 FR 2081436A1 FR 7101185 A FR7101185 A FR 7101185A FR 7101185 A FR7101185 A FR 7101185A FR 2081436 A1 FR2081436 A1 FR 2081436A1
Authority
FR
France
Prior art keywords
jan
active ingredient
drug
enhanced
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7101185A
Other languages
English (en)
French (fr)
Other versions
FR2081436B1 (cs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Pharma Solutions Inc
Original Assignee
Catalent Pharma Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Pharma Solutions Inc filed Critical Catalent Pharma Solutions Inc
Publication of FR2081436A1 publication Critical patent/FR2081436A1/fr
Application granted granted Critical
Publication of FR2081436B1 publication Critical patent/FR2081436B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/609—Amides, e.g. salicylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7101185A 1970-01-15 1971-01-14 Expired FR2081436B1 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US318870A 1970-01-15 1970-01-15
US6727670A 1970-08-26 1970-08-26

Publications (2)

Publication Number Publication Date
FR2081436A1 true FR2081436A1 (cs) 1971-12-03
FR2081436B1 FR2081436B1 (cs) 1974-08-30

Family

ID=26671450

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7101185A Expired FR2081436B1 (cs) 1970-01-15 1971-01-14

Country Status (3)

Country Link
CA (1) CA959759A (cs)
FR (1) FR2081436B1 (cs)
GB (1) GB1302471A (cs)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7409832A (nl) * 1973-07-20 1975-01-22 Scherer Ltd R P Werkwijze voor de bereiding van farmaceu- tische samenstellingen.
FR2287900A1 (fr) * 1974-10-16 1976-05-14 Arnar Stone Lab Solutions de digoxine encapsulees dans de la gelatine et leur preparation
FR2500302A1 (fr) * 1981-02-25 1982-08-27 Negma Laboratoires Nouvelles compositions pharmaceutiques d'indometacine
WO1987007149A1 (fr) * 1986-05-27 1987-12-03 Sandoz Ag Compositions pharmaceutiques
WO1988006038A1 (en) * 1987-02-20 1988-08-25 Emory University Antiinfective compounds and method of use
EP0317780A1 (en) * 1987-11-25 1989-05-31 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
US5674911A (en) * 1987-02-20 1997-10-07 Cytrx Corporation Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use
US5811088A (en) * 1987-02-20 1998-09-22 Emory University Antiinfective compounds and methods of use
US5990241A (en) * 1991-03-19 1999-11-23 Cytrx, Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US6933286B2 (en) 1991-03-19 2005-08-23 R. Martin Emanuele Therapeutic delivery compositions and methods of use thereof
US7202225B1 (en) 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB983132A (en) * 1962-04-06 1965-02-10 American Cyanamid Co Improvements in or relating to chewable hematinic tablets
NL6611190A (cs) * 1965-08-09 1967-02-10
FR2035770A1 (en) * 1969-03-14 1970-12-24 Orsymonde Antispasmodic quercetin comp having - long lasting activity

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB983132A (en) * 1962-04-06 1965-02-10 American Cyanamid Co Improvements in or relating to chewable hematinic tablets
NL6611190A (cs) * 1965-08-09 1967-02-10
FR2035770A1 (en) * 1969-03-14 1970-12-24 Orsymonde Antispasmodic quercetin comp having - long lasting activity

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2237619A1 (cs) * 1973-07-20 1975-02-14 Scherer Ltd R P
NL7409832A (nl) * 1973-07-20 1975-01-22 Scherer Ltd R P Werkwijze voor de bereiding van farmaceu- tische samenstellingen.
FR2287900A1 (fr) * 1974-10-16 1976-05-14 Arnar Stone Lab Solutions de digoxine encapsulees dans de la gelatine et leur preparation
FR2500302A1 (fr) * 1981-02-25 1982-08-27 Negma Laboratoires Nouvelles compositions pharmaceutiques d'indometacine
WO1987007149A1 (fr) * 1986-05-27 1987-12-03 Sandoz Ag Compositions pharmaceutiques
FR2599254A1 (fr) * 1986-05-27 1987-12-04 Sandoz Sa Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale.
BE1000722A4 (fr) * 1986-05-27 1989-03-21 Sandoz Sa Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale.
US5811088A (en) * 1987-02-20 1998-09-22 Emory University Antiinfective compounds and methods of use
WO1988006038A1 (en) * 1987-02-20 1988-08-25 Emory University Antiinfective compounds and method of use
US5674911A (en) * 1987-02-20 1997-10-07 Cytrx Corporation Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use
EP0317780A1 (en) * 1987-11-25 1989-05-31 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
US5990241A (en) * 1991-03-19 1999-11-23 Cytrx, Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US6359014B1 (en) 1991-03-19 2002-03-19 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US6747064B2 (en) 1991-03-19 2004-06-08 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US6933286B2 (en) 1991-03-19 2005-08-23 R. Martin Emanuele Therapeutic delivery compositions and methods of use thereof
US7202225B1 (en) 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof

Also Published As

Publication number Publication date
GB1302471A (cs) 1973-01-10
CA959759A (en) 1974-12-24
FR2081436B1 (cs) 1974-08-30

Similar Documents

Publication Publication Date Title
FR2081436B1 (cs)
RU94046044A (ru) Новые 7 бета -замещенные 4-аза- 5 альфа -холестан-оны в качестве ингибиторов 5 альфа -редуктазы, фармацевтическая композиция на их основе, способ ее получения
CA2302568A1 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
ES461399A1 (es) Procedimiento para preparar esteres de epinina con acidos carboxilicos de cadena ramificada.
IE43693L (en) Androstane derivatives
ES465906A1 (es) Un procedimiento de preparacion de comprimidos
ATE15048T1 (de) 4''-epi erythromycin a und seine derivate brauchbar wie antibakterielle mittel.
US3144387A (en) Anti-inflammatory compositions
IE39443L (en) Pharmaceutical compositions; 5-(substituted benzal)¹hydantoin derivatives
GB1488995A (en) Compositions containing anti-androgenic compounds
US3920809A (en) Dibenzo(b,d)pyranone dispersions
GB1511645A (en) Sickle cell anaemia treatment
GB1280290A (en) Novel derivatives of benzhydrylpiperazine, their process of preparation and their therapeutic application
IE903914A1 (en) Pyrimidine biosynthesis inhibitors useful as¹immunosuppressive agents
US4039668A (en) Corticoid-containing inhalants
GB1352392A (en) Phenylisopropylamine derivatives
GB1326528A (en) Method of contraception and compositions used therein
US3316151A (en) Methods and compositions for inducing tranquilizing, muscle relaxant and depressant activity
IE45096L (en) Thiadiazole derivatives
US3703580A (en) Antibacterial medicinal compositions
GB1220793A (en) Pharmaceutical compositions
GB1465771A (en) Pharmaceutical composition and use thereofd
JPS63146839A (ja) プテロシン系化合物を含んで成る制癌剤
IE37288B1 (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
IL43236A (en) 15alpha,16alpha-methylene-19-nor-delta4-pregnene-3,20-diones

Legal Events

Date Code Title Description
ST Notification of lapse